Global Market Direct’s pharmaceuticals report, “Verona Pharma Plc - Product Pipeline Review - 2013” provides data on the Verona Pharma Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Verona Pharma Plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Verona Pharma Plc and industry-specific third party sources, put together by Global Markets Direct’s team.
- Verona Pharma Plc - Brief Verona Pharma Plc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Verona Pharma Plc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Verona Pharma Plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Verona Pharma Plc’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Verona Pharma Plc’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Verona Pharma Plc in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Verona Pharma Plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Verona Pharma Plc. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Verona Pharma Plc and identify potential opportunities in those areas.
Table Of Contents
Verona Pharma Plc - Product Pipeline Review - 2013 Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Verona Pharma Plc Snapshot 4 Verona Pharma Plc Overview 4 Key Information 4 Key Facts 4 Verona Pharma Plc - Research and Development Overview 5 Key Therapeutic Areas 5 Verona Pharma Plc - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Out-Licensed Products 9 Pipeline Products - Partnered Products 10 Verona Pharma Plc - Pipeline Products Glance 11 Verona Pharma Plc Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Verona Pharma Plc - Early Stage Pipeline Products 12 Discovery Products/Combination Treatment Modalities 12 Verona Pharma Plc - Drug Profiles 13 NAIPs 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 RPL-554 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 VRP-700 16 Product Description 16 Mechanism of Action 16 RandD Progress 16 Verona Pharma Plc - Pipeline Products by Route of Administration 17 Verona Pharma Plc - Pipeline Products By Mechanism of Action 18 Verona Pharma Plc - Recent Pipeline Updates 19 Verona Pharma Plc - Dormant Projects 24 Verona Pharma Plc - Company Statement 25 Verona Pharma Plc - Locations And Subsidiaries 29 Head Office 29 Other Locations and Subsidiaries 29 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 31 Disclaimer 31